Omega Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 28-06-2024
- Paid Up Capital ₹ 3.05 Cr
as on 28-06-2024
- Company Age 30 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 38.63 Cr
as on 28-06-2024
- Revenue -18.61%
(FY 2022)
- Profit -43.91%
(FY 2022)
- Ebitda 33.41%
(FY 2022)
- Net Worth 1.05%
(FY 2022)
- Total Assets 4.62%
(FY 2022)
About Omega Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 3.05 Cr.
The company currently has active open charges totaling ₹38.63 Cr.
Rajiv Gupta, Girish Sharma, and Hariom Aggarwal serve as directors at the Company.
- CIN/LLPIN
U74899DL1994PLC060105
- Company No.
060105
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Jul 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- LocationNew Delhi, Delhi
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Omega Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Gupta  | Director | 29-Aug-2009 | Current |
| Girish Sharma | Director | 03-Oct-2011 | Current |
| Hariom Aggarwal | Director | 25-Jun-2002 | Current |
Financial Performance and Corporate Structure Insights of Omega Biotech.
Omega Biotech Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 18.61% decrease. The company also saw a substantial fall in profitability, with a 43.91% decrease in profit. The company's net worth moved up by a moderate rise of 1.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Omega Biotech?
In 2022, Omega Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 19 Jan 2017 | ₹26.01 Cr | Open |
State Bank Of India Creation Date: 08 Apr 2005 | ₹1.50 Cr | Open |
State Bank Of India Creation Date: 13 Aug 2004 | ₹11.12 Cr | Open |
How Many Employees Work at Omega Biotech?
Omega Biotech has a workforce of 72 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Omega Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omega Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
